Liver Health Goodies Our liver
Andrew Huberman, a neuroscientist and tenured professor at Stanford School of Medicine
Why was GIP receptor agonism previously considered a poor therapeutic target
Because semaglutide activates only the GLP-1 pathwaynot the GIP pathway that tirzepatide engagessome patients notice slightly less pronounced appetite reduction or require time for their body to fully respond to this simpler signaling mechanism
Compared to liraglutide, which requires daily injections and typically results in more modest weight loss, semaglutide offers a more convenient weekly dosing schedule and greater reductions in body weight
One of the most important things to consider is that at this stage in development, there is a lack of understanding as to how Retatrutide may interact with other medications, which is a key danger for anyone taking some form of prescribed medicine." She added: "Whether on medication or not, I would strongly urge people to not seek weight loss medication not yet available to the public." What has Eli Lilly said about increasing Retatrutide use